Major Drug Interaction

Can You Take Ibuprofen with Zolpidem?

Understanding the major interaction between Ibuprofen (APO-Ibuprofen 400) and Zolpidem (STILNOX Zolpidem tartrate 10mg tablet blister pack) for claims professionals, support workers, and care managers.

Major severity AllMeds interaction database Updated April 2026

Taking Ibuprofen (APO-Ibuprofen 400) with Zolpidem (STILNOX Zolpidem tartrate 10mg tablet blister pack) is a major drug interaction that should be avoided. Respiratory depression, excessive sedation, overdose. Additive CNS and respiratory depression. Z-drugs enhance GABAergic activity while opioids suppress brainstem respiratory centres.

Key Takeaways

  • Interaction severity: Major
  • Risk: Respiratory depression, excessive sedation, overdose.
  • Mechanism: Additive CNS and respiratory depression. Z-drugs enhance GABAergic activity while opioids suppress brainstem respiratory centres.
  • Ibuprofen: S2 in Australia, low risk
  • Zolpidem: S4 in Australia, moderate risk
  • Claims action: Flag for immediate prescriber review. Document intervention in claim file.

Ibuprofen vs Zolpidem at a Glance

Property Ibuprofen Zolpidem
Brand names APO-Ibuprofen 400, WGR-IBUPROFEN 400, Brufen STILNOX Zolpidem tartrate 10mg tablet blister pack, ZOLPIDEM SANDOZ PHARMA zolpidem tartrate 10 mg tablet blister pack, ZOLPIDEM SANDOZ PHARMA zolpidem tartrate 10 mg tablet bottle
Drug class opioid z drug
Risk level low moderate
TGA Schedule (AU) S2 S4

Why Is This Combination Dangerous?

Additive CNS and respiratory depression. Z-drugs enhance GABAergic activity while opioids suppress brainstem respiratory centres.

Clinical risk: Respiratory depression, excessive sedation, overdose.

Regulatory Guidance by Jurisdiction

Australia TGA / SIRA / WorkSafe

The TGA and Australian Medicines Handbook classify this as a major drug interaction requiring immediate intervention.

United Kingdom NICE / MHRA / FPM

UK clinical guidelines recommend caution with this combination. For personal injury claims, the prescribing rationale should be documented and reviewed against NICE and FPM guidance.

United States FDA / CDC / State WC

The CDC and FDA recommend monitoring concurrent CNS depressant use. State workers compensation formularies may restrict or require prior authorization for this combination.

What Claims Professionals Should Do

  1. Flag immediately as a high-risk prescribing pattern in the claim file
  2. Request urgent prescriber review with documented clinical justification for the combination
  3. Consider an independent medical examination if the prescriber cannot provide adequate justification
  4. Assess work capacity impact as the combination significantly increases sedation and impairment risk
  5. Document all interventions for audit trail and compliance purposes
  6. Check Reasonable and Necessary status for both medications against the compensable injury

Need to assess this medication across your caseload?

Check all interactions for Ibuprofen and Zolpidem across your claimant's full medication list.

AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.

No credit card required. No signup for your first 2 questions.

Related Resources

Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.